Research / TOMZ / Fundamental state Inspectable configuration
State dimensions Filing 0001654954-25-013088 General Corporate
Capex intensity 22th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
Operating cash generation 88th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-5.64% · OPTIONAL · VALID
Revenue growth 25th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.revenue
-20.88% · CORE · VALID
Inventory pressure 38th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
167.23% · OPTIONAL · VALID
Gross margin 63th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.gross_margin
61.24% · CORE · VALID
Operating margin 81th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
-15.98% · CORE · VALID
R&D intensity 0th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.53% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/6 normalized Level 3 Dec 31, 2021 0/5 normalized Level 3 Mar 31, 2022 0/5 normalized Level 3 Jun 30, 2022 0/5 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/7 normalized Level 3 Mar 31, 2023 0/7 normalized Level 3 Jun 30, 2023 0/7 normalized Level 3 Sep 30, 2023 5/7 normalized Level 3 Dec 31, 2023 5/8 normalized Level 3 Mar 31, 2024 5/6 normalized Level 3 Jun 30, 2024 5/6 normalized Level 3 Sep 30, 2024 6/7 normalized Level 3 Dec 31, 2024 6/8 normalized Level 3 Mar 31, 2025 6/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 7/9 normalized Level 3 Mar 31, 2026 7/9 normalized Level 3 Jun 30, 2026 7/9 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 0.26%
Current 0.00%
Delta -0.26% Cash Generation Increased
Previous -18.19%
Current -5.64%
Delta 12.55% Growth Increased
Previous -65.78%
Current -20.88%
Delta 44.91% Inventory Pressure Decreased
Previous 316.84%
Current 167.23%
Delta -149.61% Margin Decreased
Previous 65.67%
Current 61.24%
Delta -4.42% Profitability Increased
Previous -109.85%
Current -15.98%
Delta 93.87% R And D Intensity Decreased
Previous 8.16%
Current 0.53%
Delta -7.63% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.